← Eichor
Study identifier: NCT05286710 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb

Condition: Deep Vein Thrombosis  ·  Sponsor: RenJi Hospital

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Ipsilateral popliteal venous the most common access for pharmacomechanical thrombectomy (PMT) in the treatment of acute deep venous thrombosis (DVT), but the result was not satisfactory. The investigators adjust the access to improve the thrombus clearance rate and reduce the incidence of post-thrombotic syndrome (PTS).

This description comes directly from the study's public registry record.

Talk to the study team

Ni Qihong, M.D.  ·  +8615801900772  ·  niqihong1989@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Renji HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05286710